ethynodiol diacetate has been researched along with 17 alpha-hydroxyprogesterone caproate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Khalabi, A; Tabakman, IuIu; Vasil'eva, IA | 1 |
| Bokhman, IaV; Tkeshelashvili, VT; Vishnevskiĭ, AS | 1 |
2 other study(ies) available for ethynodiol diacetate and 17 alpha-hydroxyprogesterone caproate
| Article | Year |
|---|---|
[Results of treatment of atypical endometrial hyperplasia].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Contraceptives, Oral, Combined; Endometrial Hyperplasia; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Hydroxyprogesterones; Mestranol; Norethynodrel | 1987 |
[Planning of the treatment of atypical hyperplasia of the endometrium in patients with uterine myoma].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Age Factors; Chlormadinone Acetate; Combined Modality Therapy; Contraceptives, Oral, Combined; Dilatation and Curettage; Drug Combinations; Drug Therapy, Combination; Endometrial Hyperplasia; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Leiomyoma; Mestranol; Middle Aged; Norethindrone; Time Factors; Uterine Neoplasms | 1984 |